Download
s12885-021-08186-9.pdf 5,44MB
WeightNameValue
1000 Titel
  • Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines
1000 Autor/in
  1. Parczyk, Jonas |
  2. Ruhnau, Jérôme |
  3. Pelz, Carsten |
  4. Schilling, Max |
  5. Wu, Hao |
  6. Piaskowski, Nicole Nadine |
  7. Eickholt, Britta |
  8. Kühn, Hartmut |
  9. Danker, Kerstin |
  10. Klein, Andreas |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-30
1000 Erschienen in
1000 Quellenangabe
  • 21(1):481
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12885-021-08186-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086110/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!One key approach for anticancer therapy is drug combination. Drug combinations can help reduce doses and thereby decrease side effects. Furthermore, the likelihood of drug resistance is reduced. Distinct alterations in tumor metabolism have been described in past decades, but metabolism has yet to be targeted in clinical cancer therapy. Recently, we found evidence for synergism between dichloroacetate (DCA), a pyruvate dehydrogenase kinase inhibitor, and the HIF-1α inhibitor PX-478. In this study, we aimed to analyse this synergism in cell lines of different cancer types and to identify the underlying biochemical mechanisms.!##!Methods!#!The dose-dependent antiproliferative effects of the single drugs and their combination were assessed using SRB assays. FACS, Western blot and HPLC analyses were performed to investigate changes in reactive oxygen species levels, apoptosis and the cell cycle. Additionally, real-time metabolic analyses (Seahorse) were performed with DCA-treated MCF-7 cells.!##!Results!#!The combination of DCA and PX-478 produced synergistic effects in all eight cancer cell lines tested, including colorectal, lung, breast, cervical, liver and brain cancer. Reactive oxygen species generation and apoptosis played important roles in this synergism. Furthermore, cell proliferation was inhibited by the combination treatment.!##!Conclusions!#!Here, we found that these tumor metabolism-targeting compounds exhibited a potent synergism across all tested cancer cell lines. Thus, we highly recommend the combination of these two compounds for progression to in vivo translational and clinical trials.
1000 Sacherschließung
lokal HIF-1α inhibition
lokal Drug combination
lokal Cell Line, Tumor/drug effects [MeSH]
lokal Drug Synergism [MeSH]
lokal Phenylpropionates/pharmacology [MeSH]
lokal Synergism
lokal Experimental therapeutics and drug development
lokal Drug Screening Assays, Antitumor/methods [MeSH]
lokal Dichloroacetic Acid/pharmacology [MeSH]
lokal MCF-7 Cells [MeSH]
lokal Dichloroacetate
lokal Metabolism
lokal Research Article
lokal A549 Cells [MeSH]
lokal Dose-Response Relationship, Drug [MeSH]
lokal Cancer therapy
lokal Humans [MeSH]
lokal Reactive Oxygen Species/metabolism [MeSH]
lokal Cell Cycle Checkpoints/drug effects [MeSH]
lokal Apoptosis/drug effects [MeSH]
lokal Cell Survival/drug effects [MeSH]
lokal HT29 Cells [MeSH]
lokal Cancer cell lines
lokal Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH]
lokal PX-478
lokal Cell Proliferation/drug effects [MeSH]
lokal HeLa Cells [MeSH]
lokal Mustard Compounds/pharmacology [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9539-0587|https://frl.publisso.de/adhoc/uri/UnVobmF1LCBKw6lyw7RtZQ==|https://frl.publisso.de/adhoc/uri/UGVseiwgQ2Fyc3Rlbg==|https://frl.publisso.de/adhoc/uri/U2NoaWxsaW5nLCBNYXg=|https://frl.publisso.de/adhoc/uri/V3UsIEhhbw==|https://frl.publisso.de/adhoc/uri/UGlhc2tvd3NraSwgTmljb2xlIE5hZGluZQ==|https://frl.publisso.de/adhoc/uri/RWlja2hvbHQsIEJyaXR0YQ==|https://frl.publisso.de/adhoc/uri/S8O8aG4sIEhhcnRtdXQ=|https://frl.publisso.de/adhoc/uri/RGFua2VyLCBLZXJzdGlu|https://frl.publisso.de/adhoc/uri/S2xlaW4sIEFuZHJlYXM=
1000 Hinweis
  • DeepGreen-ID: fe2561f5da71498f9d9464bf1747cca9 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6462811.rdf
1000 Erstellt am 2023-11-15T14:41:51.662+0100
1000 Erstellt von 322
1000 beschreibt frl:6462811
1000 Zuletzt bearbeitet Thu Nov 30 20:29:44 CET 2023
1000 Objekt bearb. Thu Nov 30 20:29:44 CET 2023
1000 Vgl. frl:6462811
1000 Oai Id
  1. oai:frl.publisso.de:frl:6462811 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source